Insider Buying: Aprea Therapeutics, Inc. (NASDAQ:APRE) Director Buys 10,000 Shares of Stock
Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) Director Bernd R. Seizinger bought 10,000 shares of the firm’s stock in a transaction dated Friday, October 11th. The stock was purchased at an average cost of $2.68 per share, with a total value of $26,800.00. Following the transaction, the director now directly owns 44,730 shares in […]
More Stories
Leisure Capital Management Increases Holdings in BlackRock, Inc. (NYSE:BLK)
Leisure Capital Management increased its stake in BlackRock, Inc. (NYSE:BLK – Free Report) by 2.3% in the 3rd quarter, Holdings...
Verum Partners LLC Acquires New Shares in Abbott Laboratories (NYSE:ABT)
Verum Partners LLC bought a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the 3rd quarter,...
SeaCrest Wealth Management LLC Sells 48 Shares of Palo Alto Networks, Inc. (NASDAQ:PANW)
SeaCrest Wealth Management LLC reduced its stake in Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) by 0.7% in the...
ARC Resources (TSE:ARX) Given New C$35.00 Price Target at Scotiabank
ARC Resources (TSE:ARX – Get Free Report) had its price objective upped by stock analysts at Scotiabank from C$34.00 to...
Clearview Wealth Advisors LLC Sells 121 Shares of Emerson Electric Co. (NYSE:EMR)
Clearview Wealth Advisors LLC lessened its stake in shares of Emerson Electric Co. (NYSE:EMR – Free Report) by 3.2% during...
Tsfg LLC Has $1.17 Million Stock Holdings in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG)
Tsfg LLC decreased its position in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 3.8% in the 3rd quarter,...